Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)

ConditionsCardiac Arrest Pediatric ALL In-hospital Cardiac Arrest

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-18

SponsorJimena del Castillo

About this trial

: An intrahospital CA data recording protocol has been designed following the Utstein model. Database is hosted according to European legislation regarding patient data protection. It is drafted in English and Spanish. Invitation to participate has been sent to Spanish, European and Latinamerican hospitals. Variables included, asses hospital characteristics, the resuscitation team, patient's demographics and background, CPR, post-resuscitation care, mortality, survival and long-term evolution. Survival at hospital discharge will be evaluated as a primary outcome and survival with good neurological status as a secondary outcome, analyzing the different factors involved in them

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

all children aged 1 month to 18 years who suffer a CA in hospital

Disqualifiers

Patients being treated with extracorporeal circulatory support (ECMO or ventricular assistance) at the time of CA.

Duration of resuscitation < 1minute

Trial population

All patients who suffer a cardiac arrest in hospital premises and are resuscitated with at least 1 minute of cardiopulmonary resuscitation measures.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Cardiac arrest
Procedure/Surgery
Definition of characteristics of cardiac arrest and resuscitation as well as post-resuscitational care and follow up.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Survival

Time frame

Through study completition an average of 3 years

Secondary outcomes

Neurological outcome

Neurological outcome (Scales: Pediatric Cerecral Performance Category Scale and Pediatric Overall Performance Category Scale. Assesment of neurological outcome with both scales which attempt to measure the same items in neurological development in pediatric patients. Values of 1 or 2 describe normal recovery whilst values of 5-6 define brain death.

Time frame

5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jimena del Castillo

Lead sponsor

Hospital General Universitario Gregorio Marañon

Sponsor institution

Source ClinicalTrials.gov

Apply now